JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-7.97%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$55M
AUM Growth
+$55M
(+118%)
Cap. Flow
+$33.7M
Cap. Flow
% of AUM
61.33%
Top 10 Holdings %
Top 10 Hldgs %
77.44%
Holding
59
New
37
Increased
1
Reduced
13
Closed
5
Top Buys
| 1 |
iShares MSCI Brazil ETF
EWZ
|
$19.1M |
| 2 |
GE Aerospace
GE
|
$12.1M |
| 3 |
UnitedHealth
UNH
|
$1.47M |
| 4 |
OIBR.C
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
|
$1.23M |
| 5 |
Illumina
ILMN
|
$875K |
Top Sells
| 1 |
AB InBev
BUD
|
$5.37M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$2.39M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
$2.15M |
| 4 |
TechnipFMC
FTI
|
$923K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$386K |
Sector Composition
| 1 | Healthcare | 32.22% |
| 2 | Industrials | 22.02% |
| 3 | Communication Services | 8.22% |
| 4 | Technology | 1.46% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Brazil ETF
EWZ
$5.45B
| $19.1M | 23.2% |
+500,000
| New | +$19.1M |
|
|
2
GE Aerospace
GE
$292B
| $12.1M | 14.71% |
+1,600,000
| New | +$12.1M |
|
|
OIBR.C
3
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $4.52M | 5.49% |
2,827,201
+768,900
| +37% | +$1.23M |
|
|
4
UnitedHealth
UNH
$281B
| $1.47M | 1.78% |
+5,893
| New | +$1.47M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.05M | 1.27% |
12,292
-4,531
| -27% | -$386K |
|
6
Incyte
INCY
$16.5B
| $949K | 1.15% |
14,916
-4,534
| -23% | -$288K |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $936K | 1.14% |
16,524
-6,503
| -28% | -$368K |
|
|
8
Illumina
ILMN
$15.8B
| $875K | 1.06% |
+2,917
| New | +$875K |
|
9
PagSeguro Digital
PAGS
$2.62B
| $805K | 0.98% |
+43,000
| New | +$805K |
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $782K | 0.95% |
+7,166
| New | +$782K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $628K | 0.76% |
+6,449
| New | +$628K |
|
12
Humana
HUM
$36.5B
| $586K | 0.71% |
+2,044
| New | +$586K |
|
13
Bristol-Myers Squibb
BMY
$96B
| $546K | 0.66% |
10,496
-526
| -5% | -$27.4K |
|
14
Cigna
CI
$80.3B
| $541K | 0.66% |
+2,850
| New | +$541K |
|
|
ONC
15
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $527K | 0.64% |
+3,757
| New | +$527K |
|
16
Centene
CNC
$14.3B
| $480K | 0.58% |
+4,160
| New | +$480K |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $477K | 0.58% |
+4,983
| New | +$477K |
|
18
Boston Scientific
BSX
$156B
| $434K | 0.53% |
12,271
-615
| -5% | -$21.8K |
|
19
Abbott
ABT
$231B
| $418K | 0.51% |
+5,781
| New | +$418K |
|
20
DexCom
DXCM
$29.5B
| $411K | 0.5% |
+3,433
| New | +$411K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $372K | 0.45% |
+2,245
| New | +$372K |
|
22
Exact Sciences
EXAS
$8.98B
| $370K | 0.45% |
+5,863
| New | +$370K |
|
23
Merck
MRK
$210B
| $360K | 0.44% |
+4,716
| New | +$360K |
|
24
Exelixis
EXEL
$10.1B
| $339K | 0.41% |
17,215
-1,022
| -6% | -$20.1K |
|
25
Edwards Lifesciences
EW
$47.8B
| $338K | 0.41% |
+2,208
| New | +$338K |
|